The growth of Viagra and its effect on the medicinal landscape presents a complicated question for shareholders. While the initial sales figures were remarkable, the patent has lapsed, leading to a wave of copycat https://sairamjwf665358.blog5star.com/41769862/the-blue-pill-and-pharma-a-risky-opportunity